Welcome to LookChem.com Sign In|Join Free
  • or
2-methyl-3,5-dimethoxy-N,N-diethylbenzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

76513-55-8

Post Buying Request

76513-55-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

76513-55-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 76513-55-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,5,1 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 76513-55:
(7*7)+(6*6)+(5*5)+(4*1)+(3*3)+(2*5)+(1*5)=138
138 % 10 = 8
So 76513-55-8 is a valid CAS Registry Number.

76513-55-8Downstream Products

76513-55-8Relevant academic research and scientific papers

SOLVENT AND BASE STUDIES ON THE SITE OF ARYL METALATION OF 2-(3,5-DIMETHOXYPHENYL)-4,4-DIMETHYL-2-OXAZOLINE

Meyers, A. I.,Avila, Walter B.

, p. 3335 - 3338 (1980)

The position of metalation and alkylation in aryl oxazolines and diethylamides vary drastically when the base (RLi) and solvents are varied.

Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones

-

, (2008/06/13)

The invention relates to the use of 1,3-bis-aromatic-prop-2-en-1-ones (chalcones), 1,3-bis-aromatic-propan-1-ones (dihydrochalcones), and 1,3-bis-aromatic-prop-2-yn-1-ones for the preparation of pharmaceutical compositions for the treatment or prophylaxis of a number of serious diseases including i) conditions relating to harmful effects of inflammatory cytokines, ii) conditions involving infection by Helicobacter species, iii) conditions involving infection by viruses, iv) neoplastic disorders, and v) conditions caused by microorganisms or parasites. The invention also relates to novel chalcones and dihydrochalcones (especially alkoxy substituted variants) having advantageous substitution patterns with respect to their effect as drug substances, and to methods of preparing them, as well as to pharmaceutical compositions comprising the novel chalcones. Moreover, the present invention relates to a method for the isolation of Leishmania fumarate reductase, QSAR methodologies for selecting potent compounds for the above-mentioned purposes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 76513-55-8